about
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technol...
Read More
120.67
0.74
(0.62%)
1.1M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Illumina Inc is on 19 Nov 2025 for the purpose of Wolfe Research Healthcare Conference
See details
Medium Financial Strength
Mid Valuation
Technically Bullish
Turnaround Potential
These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors.
View Similar
Embed DVM
Illumina Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..